Human Teratogens: Current Controversies

作者: Jaime L. Frías , Enid Gilbert-Barness

DOI: 10.1016/J.YAPD.2008.07.005

关键词:

摘要: It is estimated that approximately 10% of congenital structural anomalies are the result adverse effect environmental factors on prenatal development [1]. This means 1 in 250 newborn infants have defects caused by an exposure and, presumably, a larger number children growth retardation or functional abnormalities resulting from nongenetic causes, other words, effects teratogens. A teratogen defined as any factor can produce permanent abnormality structure function, restriction growth, death embryo fetus. These comprise medications, drugs, chemicals, and maternal conditions diseases, including infections (Table 1). The term used more commonly, however, to refer only chemicals less frequently diseases may be associated with birth offspring. review uses its widest connotation. Some investigators consider there no teratogens such but teratogenicity function [2,3]. concept virtually substance capable adversely affecting conceptus if given at high enough dose known teratology Karnofsky’s law [4]. Brent [1] noted it inappropriate label agent teratogenic without characterizing dose, route exposure, stage pregnancy when occurred. because, has long been recognized, fetus depend chemical physical nature several factors, route, length exposure; developmental which occurs; genetic susceptibility mother fetus; presence

参考文章(300)
Bradley J. Van Voorhis, Outcomes From Assisted Reproductive Technology Obstetrics & Gynecology. ,vol. 107, pp. 183- 200 ,(2006) , 10.1097/01.AOG.0000194207.06554.5B
F. Marchetti, M. Romero, M. Bonati, G. Tognoni, , Use of psychotropic drugs during pregnancy - A report of the international co-operative drug use in pregnancy (DUP) study European Journal of Clinical Pharmacology. ,vol. 45, pp. 495- 501 ,(1993) , 10.1007/BF00315304
Simone E. Buitendijk, Children after in vitro fertilization. An overview of the literature. International Journal of Technology Assessment in Health Care. ,vol. 15, pp. 52- 65 ,(1999) , 10.1017/S0266462399015160
D G Trasler, Genetic determinants of teratogen-induced abnormal development in mouse and rat embryos in vitro. The International Journal of Developmental Biology. ,vol. 41, pp. 337- 344 ,(1997) , 10.1387/IJDB.9184343
J M Piper, W A Ray, F W Rosa, Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstetrics & Gynecology. ,vol. 80, pp. 429- 432 ,(1992)
Philip M. Marden, David W. Smith, Michael J. McDonald, Congenital anomalies in the newborninfant, including minor variations The Journal of Pediatrics. ,vol. 64, pp. 357- 371 ,(1964) , 10.1016/S0022-3476(64)80188-8
A. Myron Johnson, Glenn E. Palomaki, James E. Haddow, The effect of adjusting maternal serum α-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida American Journal of Obstetrics and Gynecology. ,vol. 163, pp. 9- 11 ,(1990) , 10.1016/S0002-9378(11)90655-3
Milunsky A, Jick H, Aselton P, Hunter, Stergachis A, First-trimester drug use and congenital disorders. Obstetrics & Gynecology. ,vol. 65, pp. 451- 455 ,(1985)
A. Queißer-Luft, D. Kieninger-Baum, H. Menger, G. Stolz, K. Schlaefer, E. Merz, [Does maternal obesity increase the risk of fetal abnormalities? Analysis of 20,248 newborn infants of the Mainz Birth Register for detecting congenital abnormalities]. Ultraschall in Der Medizin. ,vol. 19, pp. 40- 44 ,(2008) , 10.1055/S-2007-1000457
Lyrée N Mikhail, Cheryl K Walker, Robert Mittendorf, Association between maternal obesity and fetal cardiac malformations in African Americans. Journal of The National Medical Association. ,vol. 94, pp. 695- 700 ,(2002)